MotorTrend on MSN
The Acura TLX Is the Latest Midsize Sedan to Get the Axe
Acura is joining the chorus with its cancellation of the midsize TLX sedan after this year. The luxury brand says sales have slowed to a trickle, which is attributed in large part to the fact that, ...
Last week we asked you what cars you think are only worth it when they're fully loaded, and there was not much consensus ...
Acura's car lineup is cut in half for 2026, as its luxury sedan won't return for the new model year. However, the brand's standout hatchback—now further refined with updated standard tech and fresh ...
Polestar's flagship four-door BEV is expected to go on sale in 2026. Rivals include the aforementioned Porsche Taycan and BMW ...
Two new Acura MDX lease offers are available through November 3, 2025, with flexible terms for both loyal customers and new ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
1.4L I-4 gasoline direct injection, DOHC, VVT variable valve control, intercooled turbo, regular unleaded, engine with 155HP (1) 1.5L I-4 gasoline direct injection, DOHC, i-VTEC variable valve control ...
The 2026 Mini Countryman S brings iconic flair, while the 2025 Acura ADX delivers modern luxury. Here’s which one offers more ...
After Tesla opened up its charging network to third-party vehicles, more and more automakers are getting on board, and Honda is the latest to do so. Honda approved its cars to work with Tesla chargers ...
CarBuzz on MSN
Genesis' Final Manual Sports Sedan Is A Steal In 2025
Driving a Genesis 2.0T manual was a joyful and refreshing experience, especially given the relative rarity of manual-equipped ...
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results